Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

240.48
-0.8300-0.34%
Pre-market: 241.851.37+0.57%06:31 EDT
Volume:1.03M
Turnover:248.59M
Market Cap:15.61B
PE:16.44
High:244.46
Open:240.94
Low:239.29
Close:241.31
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:1.79
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.25
PE(LYR):-41.18

Loading ...

Jazz Pharma director Rick E. Winningham disposes of 2,741 shares for $661,744.37

Reuters
·
May 28

Jazz director Heather Ann McSharry disposes of Jazz Pharma shares worth $482,000

Reuters
·
May 28

Jazz Pharmaceuticals Phase 3 HERIZON-GEA-01 results published in NEJM

TIPRANKS
·
May 28

Jazz Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
May 28

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Barclays

TIPRANKS
·
May 27

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

TIPRANKS
·
May 23

Jazz Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 22

Bernstein Initiates Coverage on Jazz Pharmaceuticals With Market Perform Rating

MT Newswires Live
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Jazz Pharmaceuticals Plc : Piper Sandler Raises Target Price to $301 From $232

THOMSON REUTERS
·
May 22

Bernstein starts Jazz at Market Perform, says clock ticking on blockbuster drugs

TIPRANKS
·
May 22

J.P. Morgan Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
May 20

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20

Jazz Pharmaceuticals Plc : JP Morgan Resumes Coverage With Overweight Rating; Price Target $265

THOMSON REUTERS
·
May 20

Jazz Pharmaceuticals Raised to Buy From Neutral by UBS

Dow Jones
·
May 19

UBS Revises Jazz Pharmaceuticals Outlook, Citing Strong Core Business and Promising Oncology Drug

Deep News
·
May 19

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Jazz Pharmaceuticals Plc : UBS Raises to Buy From Neutral

THOMSON REUTERS
·
May 19

Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS

TIPRANKS
·
May 19

Jazz Pharma joins RBC Global Healthcare Conference fireside chat

Reuters
·
May 13